宜联生物

宜联生物

宜联生物

Biotech/Healthcare

Founded in 2020, Elpiscience Biopharma was established by a team with experience in end-to-end development of innovative antibody-drug conjugates (ADCs) and extensive corporate management expertise in China and overseas. The company develops globally competitive conjugated therapeutics and is…

Latest round: Series B (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-03-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.